tm
Seeing Is Believing
tm
Seeing Is Believing
KPTI is currently covered by 5 analysts with an average price target of $12.27. This is a potential upside of $31.72 (526.02%) from yesterday's end of day stock price of $1.96.
Karyopharm Therapeutics's activity chart (see below) currently has 57 price targets and 96 ratings on display. The stock rating distribution of KPTI is 14.29% HOLD and 85.71% BUY.
Analysts average stock forecasts to be materialized ratio is 49.78% with an average time for these price targets to be met of 365.43 days.
Highest price target for KPTI is $28, Lowest price target is $3, average price target is $12.27.
Most recent stock forecast was given by MICHAEL ULZ from BAIRD on 31-Jul-2026. First documented stock forecast 02-Jun-2015.
Currently out of the existing stock ratings of KPTI, 2 are a HOLD (14.29%), 12 are a BUY (85.71%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 03-Nov-2023
$3
$1.04 (53.06%)
$15
Buy Since 09-Oct-2025
$7
$5.04 (257.14%)
$16
Buy Since 18-Feb-2026
$3
$1.04 (53.06%)
$13
Buy Since 10-Mar-2026
$28
$22.52 (410.95%)
$330
Buy Since 06-Jan-2023
$19
$8.79 (86.09%)
What is KPTI (Karyopharm Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on KPTI (Karyopharm Therapeutics) with a proven track record?
Which analyst has the most public recommendations on KPTI (Karyopharm Therapeutics)?
Which analyst is the currently most bullish on KPTI (Karyopharm Therapeutics)?
Which analyst is the currently most reserved on KPTI (Karyopharm Therapeutics)?
